SUMMARY 55Fe-labelled transferrin was injected into the synovial fluid before synovectomy in 6 patients with rheumatoid arthritis. The results show that transferrin iron is taken up by synovial macrophages.
The synovium of patients with rheumatoid arthritis contains more than the normal amount of stainable iron (Mowat and Hotherstall, 1968; Muirden and Senator, 1968) despite the frequent presence of anaemia and sideropenia. In this respect the synovium mimics the reticuloendothelial iron stores of the marrow which in this disease may also contain increased quantities of iron. The marrow iron may come from the breakdown of worn out red cells, while in the synovium local bleeding as a result of joint damage may supply iron to the tissue macrophages. It is, however, possible that cells of the reticuloendothelial system may take up at least some of their iron from transferrin. Although Lynch et al. (1974) concluded that reticuloendothelial cells do not take up iron from transferrin, other workers (MacSween and MacDonald, 1969; O'Shea et al., 1973) have shown that iron uptake from transferrin is possible in vitro. This study was undertaken to investigate whether synovial tissue macrophages can take up labelled transferrin iron in vivo and hence whether their intracellular iron could be in part derived from the same source.
Methods
The study was carried out in 6 patients who were to undergo synovectomy. All were suffering from classical or definite rheumatoid arthritis (Ropes et al., 1959) . Their haemoglobin concentrations were between 13 g/dl and 14 g/dl, with a mean corpuscular volume of 77-88 fl. Fully informed consent to participate in this study was obtained from each patient.
Approximately 2 hours before operation 10 ml venous blood was taken from each patient and the plasma transferrin labelled with 55Fe by the method Accepted for publication February 7, 1977 Correspondence to Dr. I. Cavill of Cavill (1971) . 5 ml labelled plasma was injected into the synovial fluid of the appropriate joint approximately one hour before synovectomy. The whole of the synovial tissue which was removed was immediately fixed in phosphate-buffered formalin pH 7 2. After 16 hours' dehydration portions of the tissue were embedded in wax. 5 gtm sections were cut serially and mounted on glass slides which had been dipped in a solution containing 0 5 g chrome alum and 5 0 g gelatine per litre. They were then heated at 60°C for one hour, dewaxed, and passed through alcohol to water. Autoradiographs were prepared by a stripping technique using Kodak AR 10 stripping film. The coated slides were dried thoroughly, transferred to lightproof boxes, and kept at 4°C for periods of up to 4 months. After this time the film was developed and the section counterstained with Mayer's haematoxylin.
Results
After 2 months' exposure, 5 of the 6 patients showed evidence of an accumulation of 55Fe in synovial tissues. This appeared to be localized in macrophages below the superficial synovial cells (Fig. 1 ) and was consistently absent from plasma cells. Within the macrophages 55Fe appeared to be confined to the cytoplasm. The nucleus did not take up any of the label (Fig. 2) .
Discussion
The 55Fe injected into the synovium of each patient was attached specifically and solely to transferrin. During the hour that the synovium was bathed by the labelled transferrin an unknown amount of 55Fe would have moved from the joint into plasma and thence into developing red cells. These red cells would not, however, have been released into the circulation until after synovectomy. The only source therefore of the intracellular 55Fe was that on transferrin in the synovial fluid. Our results show that tissue macrophages can, and do, accumulate iron from their transferrin-containing milieu.
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In rheumatoid disease macrophages in both the synovium and reticuloendothelial system contain increased quantitites of storage iron. The results of the present study have shown that transferrin iron can be taken up directly by these cells. Moreover, a proportion of this iron will undoubtedly become incorporated in the intracellular ferritin stores. The degree to which this occurs and the contribution it may make to the increased stores and concurrent sideropenia in these patients must remain speculative. It 
